1st Oct 2021 17:55
MaxCyte Inc - Maryland, US-based biotechnology company - Chair J Stark Thompson to step down with effect from the company's annual general meeting on October 29.
MaxCyte stresses that the decision is not related to "any disagreement relating to the company's operations, policies or practices".
Thompson has been part of the company for 20 years since 2001.
"On behalf of the board and the entire MaxCyte team, we wish to thank Thompson for his service and guidance on the board over the years," says Chief Executive Officer Doug Doerfler.
Current stock price: 812.00 pence, down 9.8% on Friday
Year-to-date change: up 54%
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
MaxCyte